Route design before execution
We start by clarifying market priorities, product classification, evidence gaps, and timing risk.
LLINS Tech
Since 2017, LLINS Tech has helped medical device and IVD teams align regulatory strategy, dossier readiness, representative coverage, quality systems, and clinical evidence planning across China, the EU, the US, Southeast Asia, India, Saudi Arabia, and other priority markets.
Engagement Snapshot
We start by clarifying market priorities, product classification, evidence gaps, and timing risk.
Technical documentation, testing, clinical rationale, and quality requirements are aligned as one track.
China, EU, US, and representative services are handled with continuity instead of isolated handoffs.
Regional Coverage
LLINS Tech also supports regulatory planning, dossier adaptation, registration readiness, and cross-market coordination for Southeast Asia, India, and Saudi Arabia.
Support for Singapore, Malaysia, Thailand, Vietnam, and Indonesia across market-entry planning, document adaptation, and local coordination.
Support for regulatory pathway planning, submission preparation, documentation alignment, and execution pacing for the Indian market.
Support for route assessment, evidence packaging, submission readiness, and ongoing compliance preparation for Saudi market access.
Selected Clients
These marks offer a quick view of the organizations and brands represented across past project work.




















Core Services
Instead of splitting regulatory work into isolated tasks, LLINS Tech combines strategy, dossier support, quality systems, and representative services into a more coherent delivery flow.
Build a clearer route based on target markets, classification, evidence requirements, and business priorities.
Support MDR / IVDR readiness, CE documentation, testing plans, clinical alignment, and EU representative coordination.
Support FDA pathway assessment, 510(k) preparation, QMSR alignment, and US representative service requirements.
Coordinate NMPA submission readiness, innovative product strategy, and local evidence expectations.
Connect ISO 13485, MDSAP, and QMSR expectations with the documentation work needed for approvals.
Support performance studies, clinical evaluation logic, overseas testing coordination, and evidence packaging.
Delivery Model
Speed matters in regulatory programs, but speed on the wrong route creates more waste. The delivery model is designed to reduce that risk early.
Review target markets, classification, existing evidence, testing gaps, and quality system maturity.
Set priorities, key deliverables, representative needs, and realistic milestones for the program.
Link technical files, testing work, clinical evidence, and quality actions into one coordinated timeline.
Prepare for submission, post-market obligations, representative support, and future market expansion.
Operating Footprint
Public company information shows operating contacts in Shanghai and Hangzhou, together with links to representative resources in Germany, the UK, the US, and overseas testing collaboration.
Contact
A short first discussion can align the target market, device class, timing constraints, and dossier readiness.
Allan Zhang
allan.zhang@llins-tech.com +86 139 1626 5813 Room 1115, Building A, Xuhui Vanke Center, No.55 Ding'an Road, Xuhui District, ShanghaiChunquan Song
chunquan.song@llins-tech.com +86 183 5850 0842 Room 1012, Tianheng Building, 1509 Binsheng Road, Binjiang District, Hangzhou, ZhejiangMolly Fan
mengyu.fan@llins-tech.com +86 133 7256 8762 Room 1012, Tianheng Building, 1509 Binsheng Road, Binjiang District, Hangzhou, ZhejiangStart With Clarity